Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT01462565 · COMPLETED

Trial details

NCT number: NCT01462565
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension, Pulmonary

Start date: 2011-11-01
Primary completion: 2012-05-16
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.